The introduction of a new heart marker enables BBI Solutions to diversify its antibody offering in the Cardiac Marker Testing Devices Market on a global scale. In 2016, approximately 47% of the elderly population in the United States had at least one of the three major risk factors for cardiovascular disease (CVD), which include uncontrolled high blood pressure, uncontrolled high LDL cholesterol, and smoking. This information comes from a report by the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP). Controlling these elements, however, could cut the chance of a heart attack by 80%. In 2017, BBI Solutions a developer and marketer of test platforms for in-vitro diagnostic procedures announced the introduction of myoglobin antibiotics as a cardiac marker. Before being used in patient screening processes and commercial assay procedures, these cardiac markers were tested in an ELISA assay.
Read more @ https://creativeedge16.blogspot.com/2022/12/cardiac-marker-testing-devices-market.html
